Resultados da pesquisa - van Dussen, Laura

Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease Por van Dussen, Laura, Biegstraaten, Marieke, Hollak, Carla EM, Dijkgraaf, Marcel GW

Obter o texto integral Obter o texto integral Obter o texto integral

Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications Por van Dussen, Laura, Biegstraaten, Marieke, Dijkgraaf, Marcel GW, Hollak, Carla EM

Obter o texto integral Obter o texto integral Obter o texto integral

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease Por El Sayed, Mohamed, Hirsch, Alexander, Boekholdt, Matthijs, van Dussen, Laura, Datema, Mareen, Hollak, Carla, Langeveld, Mirjam

Obter o texto integral Obter o texto integral Obter o texto integral

What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites Por Tamminga, Saskia, van Dussen, Laura, Verweij, E. J. (Joanne), de Boer, Marjon A., Cornel, Martina C., Henneman, Lidewij

Obter o texto integral Obter o texto integral Obter o texto integral

Liver Fibrosis in Type I Gaucher Disease: Magnetic Resonance Imaging, Transient Elastography and Parameters of Iron Storage Por Bohte, Anneloes E., van Dussen, Laura, Akkerman, Erik M., Nederveen, Aart J., Sinkus, Ralph, Jansen, Peter L. M., Stoker, Jaap, Hollak, Carla E. M.

Obter o texto integral Obter o texto integral Obter o texto integral

Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa Por Zimran, Ari, Dinur, Tama, Revel-Vilk, Shoshana, Akkerman, Eric M., van Dussen, Laura, Hollak, Carla E. M., Maayan, Hannah, Altarescu, Gheona, Chertkoff, Raul, Maas, Mario

Obter o texto integral Obter o texto integral Obter o texto integral

Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes Por van Dussen, Laura, Cox, Timothy M., Hendriks, Erik J., Morris, Elizabeth, Akkerman, Erik M., Maas, Mario, Groener, Johanna E. M., Aerts, Johannes M.F.G., Deegan, Patrick B., Hollak, Carla E. M.

Obter o texto integral Obter o texto integral Obter o texto integral

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease Por van der Veen, Sanne J., Vlietstra, Wytze J., van Dussen, Laura, van Kuilenburg, André B.P., Dijkgraaf, Marcel G. W., Lenders, Malte, Brand, Eva, Wanner, Christoph, Hughes, Derralynn, Elliott, Perry M., Hollak, Carla E. M., Langeveld, Mirjam

Obter o texto integral Obter o texto integral Obter o texto integral

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response Por Dekker, Nick, van Dussen, Laura, Hollak, Carla E. M., Overkleeft, Herman, Scheij, Saskia, Ghauharali, Karen, van Breemen, Mariëlle J., Ferraz, Maria J., Groener, Johanna E. M., Maas, Mario, Wijburg, Frits A., Speijer, Dave, Tylki-Szymanska, Anna, Mistry, Pramod K., Boot, Rolf G., Aerts, Johannes M.

Obter o texto integral Obter o texto integral Obter o texto integral

Hepatocellular carcinoma in Gaucher disease: an international case series Por Regenboog, Martine, van Dussen, Laura, Verheij, Joanne, Weinreb, Neal J., Santosa, David, vom Dahl, Stephan, Häussinger, Dieter, Müller, Meike N., Canbay, Ali, Rigoldi, Miriam, Piperno, Alberto, Dinur, Tama, Zimran, Ari, Mistry, Pramod K., Salah, Karima Yousfi, Belmatoug, Nadia, Kuter, David J., Hollak, Carla E. M.

Obter o texto integral Obter o texto integral Obter o texto integral